{
    "2019-12-28": [
        [
            {
                "time": "",
                "original_text": "百济神州PD-1今日获批，2+4竞争格局正式形成，下一程比什么？",
                "features": {
                    "keywords": [
                        "百济神州",
                        "PD-1",
                        "获批",
                        "竞争格局"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "自制药剂成负担？上海这项合作给医院减负，还能让中药升级",
                "features": {
                    "keywords": [
                        "自制药剂",
                        "负担",
                        "上海合作",
                        "医院减负",
                        "中药升级"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "中医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}